Correlation Between Marizyme and Arch Biopartners

Can any of the company-specific risk be diversified away by investing in both Marizyme and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marizyme and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Marizyme and Arch Biopartners, you can compare the effects of market volatilities on Marizyme and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marizyme with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marizyme and Arch Biopartners.

Diversification Opportunities for Marizyme and Arch Biopartners

0.0

Correlation Coefficient

Marizyme  Arch Biopartners

Pay attention - limited upside

The 3 months correlation between Marizyme and Arch is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Marizyme and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Marizyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marizyme are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Marizyme i.e., Marizyme and Arch Biopartners go up and down completely randomly.

Pair Corralation between Marizyme and Arch Biopartners

If you would invest  126.00  in Arch Biopartners on May 6, 2025 and sell it today you would lose (1.00) from holding Arch Biopartners or give up 0.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	96.88%
Values	Daily Returns

Marizyme  vs.  Arch Biopartners

Marizyme

Risk-Adjusted Performance

Very Weak

Over the last 90 days Marizyme has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Marizyme is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Arch Biopartners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arch Biopartners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Arch Biopartners is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Marizyme and Arch Biopartners

The main advantage of trading using opposite Marizyme and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marizyme position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.

The idea behind Marizyme and Arch Biopartners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.